Someone was asking why Titijaya didn’t include vaccine in their business agreement with Sinopharm back in April Bursa announcement.
The answer is simple. It’s because there was no approval on Sinopharm vaccine back in April. But now we are in August 2020, the Covid19 Vaccine from Sinopharm is in final stage and have obtain approval on their vaccine production line from China government. It’s matter of time for Titijaya to come out and say vaccine is included too.
Titijaya is Sinopharm business partner in Malaysia and Malaysia government has already informed us that Malaysia will be the vaccine hub for South East Asia capitalising on China’s medical advancement.
Titijaya has plenty of landbank in Malaysia for the development of such medical hub and for vaccine distribution purposes.
Titijaya as the business partner of Sinopharm in Malaysia, they will be the biggest beneficiary of this mega development.
Some even question how fast can the hub be built. Not to forget with today’s technology advancement, China is able to build 2 hospitals within 10-12 days. Hence, under such urgency, I supppse there will be fast track approval on the construction of the hub in Malaysia too.
Titijaya is already undervalued if purely based on its NTA of 0.86. Now they are diversifying their business into medical field. With Tan Sri Lim network within the region, it’s definitely a big bargain to buy Titijaya at 0.46. If everything materialise, Titijaya should be priced much much higher than its current market price. Some say above RM3! Haha. We wish it’s true too.
But I think many people are not aware yet, that’s why I keep saying Titijaya is the biggest Vaccine GEM yet to be uncovered!
Good luck everyone. If you have missed other glove or vaccine counters which have already went up so much, here in Titijaya, it is just about to start the long and interesting rally journey!
GENEVA (Aug 7): Six Covid-19 vaccine candidates, including three from China, have entered Phase 3 trials, reported the Xinhua News Agency, quoting senior World Health Organization (WHO) official yesterday.
The three Chinese candidates are from Sinovac, Wuhan Institute of Biological Products/Sinopharm, and Beijing Institute of Biological Products/Sinopharm, said Michael Ryan, the executive director of the WHO Health Emergencies Programme, at a virtual briefing.
The other three are made by the University of Oxford/AstraZeneca, Moderna/NIAID, and BioNTech/Fosun Pharma/Pfizer, he added.
The vaccines will be put into the general population for the first time in Phase 3 after previous trials focused on safety, immunogenicity and immune response in a small number of humans, said the WHO official. The Phase 3 trial will test whether the vaccines can "protect large numbers of people over a prolonged period of time".
IWC limit up with partnership CREC on Bandar Malaysia. Titijaya limit up with partnership with Sinopharma on medical related business included PPE, vaccine, pharma plant (vaccine hub).....
Buddy, Got one potential one to share, just sold out NOTION and all in the stock, this baby venture into PPE covid related products, also potential FDA approval PPE products like NOTION, still very undervalued, potential to be limit up like NOTION... Just sharing...
Newbie0001 Buddy, Got one potential one to share, just sold out NOTION and all in the stock, this baby venture into PPE covid related products, also potential FDA approval PPE products like NOTION, still very undervalued, potential to be limit up like NOTION... Just sharing...
Don't anyhow buy China company listed in Bursa, SGX...even in HKEX n DJ or NASDAQ...be careful...better don't touch them if u don't understand...lot of fake earnings growth...ಠ︵ಠ
NATION PM: Msia ready to provide support for Covid-19 vaccine development [NSTTV] By Adib Povera, Rizalman Hammim August 8, 2020 @ 2:00pm
PAGOH: Malaysia is prepared to provide assistance in the development of a Covid-19 vaccine, which is being undertaken by several countries around the world.
Prime Minister Tan Sri Muhyiddin Yassin said in April, the Health Ministry established a task force to look into providing support for developing a vaccine for the deadly virus.
"This effort is to explore strategic cooperation opportunities with other countries in the research and development of vaccines and medicines for Covid-19," said Muhyiddin in his speech at the launch of the Embracing New Norms campaign here, today.
The government, he said, is monitoring closely the Covid-19 situation not only in the country but also around the world. –– ADVERTISEMENT ––
"I learned that several countries are in the process of developing a vaccine for Covid-19.
"However, it is likely that the process of developing the vaccine will take some time and most likely (the process could be completed) by early 2021," he said.
It was reported that researchers and pharmaceutical companies around the world are racing to develop and test a vaccine for the virus.
AFP last month reported that there are more than 150 projects on vaccine development by private Chinese pharmaceutical firm Sinovac Biotech.
According to the same report, the vaccine has entered the final stage of testing in Brazil, where volunteers received the first dose.
In another report, a study by the New England Journal of Medicine found that a vaccine developed by a United States biotech firm has managed to induce a robust immune response and prevented the virus from replicating in the noses and lungs of monkeys.
The vaccine by Moderna, according to the report, uses genetic material in the form of viral ribonucleic acid to encode the information needed to grow the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike protein inside the body of humans, which will subsequently trigger an immune response.
RELATED ARTICLES
NATION Aug 8, 2020 @ 12:23pm PM: All Malaysians are frontliners in Covid-19 fight [NSTTV]
NATION Aug 8, 2020 @ 1:43pm PM launches 'Embracing New Norms' campaign.
titijaya PA can change 10 to 1 mother.. ie.. 60 sen for 10 PA, which u can convert to 1000 share titijaya..which worth 68 to 70 sen depending on the mother share price
Seeing the mothershare is on the way beyond RM1 with the linkage to SINOPHARM and the vaccine development news, this TITIJYA-PA warrant looks like a very lucrative deal
This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....
pang72
51,625 posts
Posted by pang72 > 2020-08-08 12:41 | Report Abuse
Don't worry!
My diehard followers in i3 will make it limit up on Monday...
Titijaya will replace my SUPERNICE!!
IT BECOME SUPER JAYA!!
HAHA!!